Mi-Hua Liu

Dr. Mi-Hua Liu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
XLXiao-Long Lin
Xiao-Long Lin
LXLe-Le Xiao
Le-Le Xiao
ZTZhi-Han Tang
Zhi-Han Tang
ZJZhi-Sheng Jiang
Zhi-Sheng Jiang
MLMi-Hua Liu
Mi-Hua Liu

4 December 2014 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MLMi-Hua Liu
Mi-Hua Liu
CYCong Yuan
Cong Yuan
JHJun He
Jun He
TTTian-Ping Tan
Tian-Ping Tan
SWShao-Jian Wu
Shao-Jian Wu
XLXiaolong Lin
Xiaolong Lin

9 December 2015 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
MLMi-Hua Liu
Mi-Hua Liu
XLXiao-Long Lin
Xiao-Long Lin
DGDong-Ming Guo
Dong-Ming Guo
YZYuan Zhang
Yuan Zhang
CYCong Yuan
Cong Yuan
JHJun He
Jun He
Doxorubicin (DOX) is an efficient drug used in cancer therapy; however, it has severe cardiotoxic side effects. The aim of the present study was to investigate the effects of resveratrol on the adenosine monophosphate-activated protein kinase (AMPK)/P53 pathway in mediating DOX-induced cytotoxicity. H9c2 cells were exposed to 5 µM DOX for 24 h to establish a model of DOX-induced cardiotoxicity. DOX administration amplified P53 and B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax) expression and decreased Bcl-2 expression in H9c2 cells. Resveratrol increased the cell viability and decreased the apoptotic rate. In addition, resveratrol markedly increased the phosphorylation of AMPK. Of note, resveratrol protected against DOX-induced increases of P53 and Bax and also prevented the downregulation of Bcl-2 in H9c2 cells. Furthermore, AMPK inhibitor Compound C abolished the protective effects of resveratrol. The results of the present study therefore indicated that resveratrol protected H9c2 cells from DOX-induced apoptosis via the AMPK/P53 pathway.

16 May 2018 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
XLXiao‑Long Lin
Xiao‑Long Lin
WXWei‑Jin Xiao
Wei‑Jin Xiao
LXLe‑Le Xiao
Le‑Le Xiao
MLMi-Hua Liu
Mi-Hua Liu
Autophagy is a maintenance process for recycling long-lived proteins and cytoplasmic organelles. The level of this process is enhanced during ischemia/reperfusion (I/R) injury. Autophagy can trigger survival signaling in myocardial ischemia, whereas defective autophagy during reperfusion is detrimental. Autophagy can be regulated through multiple signaling pathways in I/R, including Beclin‑1/class III phosphatidylinositol‑3 kinase (PI‑3K), adenosine monophosphate activated protein kinase/mammalian target of rapamycin (mTOR), and PI‑3K/protein kinase B/mTOR pathways, which consequently lead to different functions. Thus, autophagy has both protective and detrimental functions, which are determined by different signaling pathways and conditions. Targeting the activation of autophagy can be a promising new therapeutic strategy for treating cardiovascular disease.

22 February 2016 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MLMi-Hua Liu
Mi-Hua Liu
GLGuo-Hua Li
Guo-Hua Li
LPLi-Jun Peng
Li-Jun Peng
SQShun-Lin Qu
Shun-Lin Qu
YZYuan Zhang
Yuan Zhang
ZJZhisheng Jiang
Zhisheng Jiang

31 January 2017 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
XLXiaolong Lin
Xiaolong Lin
YLYuanbo Liu
Yuanbo Liu
MLMi-Hua Liu
Mi-Hua Liu
HHHuiJun Hu
HuiJun Hu
YPYongquan Pan
Yongquan Pan
WZWei-Wen Zou
Wei-Wen Zou
BACKGROUND:The abnormal activity of Sirtuin 1 (Sirt1) is closely related to the aging of vascular endothelial cells. As a bioactive molecule, allicin has antioxidant, anti-inflammatory, and lipid-regulating mechanisms. However, few reports about the ...